Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- Nutraceutical Clinical Laboratories International, Inc., Secures $2 Million in Funding
- KAVA ADVISORY: Health Canada is advising consumers not to use any products containing kava
- FDA Statement on Tenth Circuit’s Ruling to Uphold FDA Decision Banning Dietary Supplements Containing Ephedrine Alkaloids
FDA states that no dosage of dietary supplements containing ephedrine alkaloids is safe and the sale of these products in the United States is illegal and subject to FDA enforcement action.
- FDA Statement on Tenth Circuit’s Ruling to Uphold FDA Decision Banning Dietary Supplements Containing Ephedrine Alkaloids
FDA states that no dosage of dietary supplements containing ephedrine alkaloids is safe and the sale of these products in the United States is illegal and subject to FDA enforcement action.
- FDA Statement on Tenth Circuit’s Ruling to Uphold FDA Decision Banning Dietary Supplements Containing Ephedrine Alkaloids
FDA states that no dosage of dietary supplements containing ephedrine alkaloids is safe and the sale of these products in the United States is illegal and subject to FDA enforcement action.
- Government of Canada Awards Site License to Sangster’s Health Centres
Sangster’s Health Centres, (a member of Planet Organic Health Corp. POH-TSX Venture Exchange), announces that Darwen Holdings, the product distribution division of Sangster’s Health Centres has been awarded a site license under The Government of Canada’s Natural Health Products Regulations (NHP).
- Government of Canada Awards Site License to Sangster’s Health Centres
Sangster’s Health Centres, (a member of Planet Organic Health Corp. POH-TSX Venture Exchange), announces that Darwen Holdings, the product distribution division of Sangster’s Health Centres has been awarded a site license under The Government of Canada’s Natural Health Products Regulations (NHP).
- Government of Canada Awards Site License to Sangster’s Health Centres
Sangster’s Health Centres, (a member of Planet Organic Health Corp. POH-TSX Venture Exchange), announces that Darwen Holdings, the product distribution division of Sangster’s Health Centres has been awarded a site license under The Government of Canada’s Natural Health Products Regulations (NHP).
- AHPA Submits Comments to US Forest Service on Native Plants Proposal
AHPA has submitted comments to the US Forest Service (USFS) last Friday, specifically to request that the term "native plant" be defined in language that is consistent with other federal definitions of the term, and to suggest greater clarity in a newly proposed policy statement. (May 26 USFS proposal to establish a new directive in Forest Service Manual 2070 for native plant materials.)
- AHPA Submits Comments to US Forest Service on Native Plants Proposal
AHPA has submitted comments to the US Forest Service (USFS) last Friday, specifically to request that the term "native plant" be defined in language that is consistent with other federal definitions of the term, and to suggest greater clarity in a newly proposed policy statement. (May 26 USFS proposal to establish a new directive in Forest Service Manual 2070 for native plant materials.)
- Consumer Protection Deputy Director To Leave FTC
C. Lee Peeler, deputy director of the Bureau of Consumer Protection for the past five years, will leave the FTC, to become president of the National Advertising Review Council and Executive Vice President for National Advertising and Self-Regulation of the Council of Better Business Bureaus.
- Consumer Protection Deputy Director To Leave FTC
C. Lee Peeler, deputy director of the Bureau of Consumer Protection for the past five years, will leave the FTC, to become president of the National Advertising Review Council and Executive Vice President for National Advertising and Self-Regulation of the Council of Better Business Bureaus.
- Consumer Protection Deputy Director To Leave FTC
C. Lee Peeler, deputy director of the Bureau of Consumer Protection for the past five years, will leave the FTC, to become president of the National Advertising Review Council and Executive Vice President for National Advertising and Self-Regulation of the Council of Better Business Bureaus.
- Consumer Protection Deputy Director To Leave FTC
C. Lee Peeler, deputy director of the Bureau of Consumer Protection for the past five years, will leave the FTC, to become president of the National Advertising Review Council and Executive Vice President for National Advertising and Self-Regulation of the Council of Better Business Bureaus.
- Consumer Protection Deputy Director To Leave FTC
C. Lee Peeler, deputy director of the Bureau of Consumer Protection for the past five years, will leave the FTC, to become president of the National Advertising Review Council and Executive Vice President for National Advertising and Self-Regulation of the Council of Better Business Bureaus.
- UK: Comments wanted on phytosterol
French company, DRT, has asked for a decision on its phytosterol ingredient, which is derived from tall oil pitch – a substance distilled from pine resin.
- UK: Comments wanted on phytosterol
French company, DRT, has asked for a decision on its phytosterol ingredient, which is derived from tall oil pitch – a substance distilled from pine resin.
- UK: Comments wanted on phytosterol
French company, DRT, has asked for a decision on its phytosterol ingredient, which is derived from tall oil pitch – a substance distilled from pine resin.
- UK: Comments wanted on phytosterol
French company, DRT, has asked for a decision on its phytosterol ingredient, which is derived from tall oil pitch – a substance distilled from pine resin.
- UK: Comments wanted on phytosterol
French company, DRT, has asked for a decision on its phytosterol ingredient, which is derived from tall oil pitch – a substance distilled from pine resin.
- TGA Approves EPAX’S Omega-3 Oils For Use In Australia’s Complementary Medicine Products
Company announced that after 18 months of working closely with its Australian distributor Pathway International, it has been granted regulatory approval from Australia’s Therapeutic Goods Administration (TGA), allowing EPAX’s range of omega-3 oils to be used in complementary medicine products in Australia.
- TGA Approves EPAX’S Omega-3 Oils For Use In Australia’s Complementary Medicine Products
Company announced that after 18 months of working closely with its Australian distributor Pathway International, it has been granted regulatory approval from Australia’s Therapeutic Goods Administration (TGA), allowing EPAX’s range of omega-3 oils to be used in complementary medicine products in Australia.
- TGA Approves EPAX’S Omega-3 Oils For Use In Australia’s Complementary Medicine Products
Company announced that after 18 months of working closely with its Australian distributor Pathway International, it has been granted regulatory approval from Australia’s Therapeutic Goods Administration (TGA), allowing EPAX’s range of omega-3 oils to be used in complementary medicine products in Australia.
- TGA Approves EPAX’S Omega-3 Oils For Use In Australia’s Complementary Medicine Products
Company announced that after 18 months of working closely with its Australian distributor Pathway International, it has been granted regulatory approval from Australia’s Therapeutic Goods Administration (TGA), allowing EPAX’s range of omega-3 oils to be used in complementary medicine products in Australia.
- TGA Approves EPAX’S Omega-3 Oils For Use In Australia’s Complementary Medicine Products
Company announced that after 18 months of working closely with its Australian distributor Pathway International, it has been granted regulatory approval from Australia’s Therapeutic Goods Administration (TGA), allowing EPAX’s range of omega-3 oils to be used in complementary medicine products in Australia.
- Cargill Expands GRAS Status of Oliggo-Fiber® Inulin and Oligofructose Products
Company has expanded the GRAS (Generally Recognized As Safe) status of its Oliggo-Fiber® brand of inulin and oligofructose products through an independent evaluation by a qualified scientific expert, permitting the Oliggo-Fiber inulin and oligofructose line of products for general use in foods at levels consistent with current good manufacturing practice.
- Cargill Expands GRAS Status of Oliggo-Fiber® Inulin and Oligofructose Products
Company has expanded the GRAS (Generally Recognized As Safe) status of its Oliggo-Fiber® brand of inulin and oligofructose products through an independent evaluation by a qualified scientific expert, permitting the Oliggo-Fiber inulin and oligofructose line of products for general use in foods at levels consistent with current good manufacturing practice.
- Cargill Expands GRAS Status of Oliggo-Fiber® Inulin and Oligofructose Products
Company has expanded the GRAS (Generally Recognized As Safe) status of its Oliggo-Fiber® brand of inulin and oligofructose products through an independent evaluation by a qualified scientific expert, permitting the Oliggo-Fiber inulin and oligofructose line of products for general use in foods at levels consistent with current good manufacturing practice.
- Cargill Expands GRAS Status of Oliggo-Fiber® Inulin and Oligofructose Products
Company has expanded the GRAS (Generally Recognized As Safe) status of its Oliggo-Fiber® brand of inulin and oligofructose products through an independent evaluation by a qualified scientific expert, permitting the Oliggo-Fiber inulin and oligofructose line of products for general use in foods at levels consistent with current good manufacturing practice.
- Hi-Fil® Lutein Achieves GRAS Status
Hi-Fil® Lutein products, manufactured by Industrial Organica and distributed exclusively by Pharmline Inc., has attained self-affirmed GRAS (Generally Recognized As Safe) status, through an independent evaluation by an expert panel of scientists.
- Hi-Fil® Lutein Achieves GRAS Status
Hi-Fil® Lutein products, manufactured by Industrial Organica and distributed exclusively by Pharmline Inc., has attained self-affirmed GRAS (Generally Recognized As Safe) status, through an independent evaluation by an expert panel of scientists.
- Hi-Fil® Lutein Achieves GRAS Status
Hi-Fil® Lutein products, manufactured by Industrial Organica and distributed exclusively by Pharmline Inc., has attained self-affirmed GRAS (Generally Recognized As Safe) status, through an independent evaluation by an expert panel of scientists.
- Hi-Fil® Lutein Achieves GRAS Status
Hi-Fil® Lutein products, manufactured by Industrial Organica and distributed exclusively by Pharmline Inc., has attained self-affirmed GRAS (Generally Recognized As Safe) status, through an independent evaluation by an expert panel of scientists.
- Sabinsa Secures Approval From Government of India to Use Its Ocufors(TM) Eye Drop Solution for Glaucoma Treatment
Company has been granted permission by the Drugs Controller General of India to manufacture and market Ocufors(TM), an ophthalmic solution containing one percent forskolin, for the treatment of glaucoma.
- Sabinsa Secures Approval From Government of India to Use Its Ocufors(TM) Eye Drop Solution for Glaucoma Treatment
Company has been granted permission by the Drugs Controller General of India to manufacture and market Ocufors(TM), an ophthalmic solution containing one percent forskolin, for the treatment of glaucoma.
- Sabinsa Secures Approval From Government of India to Use Its Ocufors(TM) Eye Drop Solution for Glaucoma Treatment
Company has been granted permission by the Drugs Controller General of India to manufacture and market Ocufors(TM), an ophthalmic solution containing one percent forskolin, for the treatment of glaucoma.
- Sabinsa Secures Approval From Government of India to Use Its Ocufors(TM) Eye Drop Solution for Glaucoma Treatment
Company has been granted permission by the Drugs Controller General of India to manufacture and market Ocufors(TM), an ophthalmic solution containing one percent forskolin, for the treatment of glaucoma.
- NSF International Awards First GMP for Sport(TM) Registration to Century Foods International
NSF International announced that Century Foods International is the first manufacturing facility to receive Good Manufacturing Practices (GMP) for Sport™ registration, a new program that builds on NSF’s GMP Registration Program.
- NSF International Awards First GMP for Sport(TM) Registration to Century Foods International
NSF International announced that Century Foods International is the first manufacturing facility to receive Good Manufacturing Practices (GMP) for Sport™ registration, a new program that builds on NSF’s GMP Registration Program.
- NSF International Awards First GMP for Sport(TM) Registration to Century Foods International
NSF International announced that Century Foods International is the first manufacturing facility to receive Good Manufacturing Practices (GMP) for Sport™ registration, a new program that builds on NSF’s GMP Registration Program.
- NSF International Awards First GMP for Sport(TM) Registration to Century Foods International
NSF International announced that Century Foods International is the first manufacturing facility to receive Good Manufacturing Practices (GMP) for Sport™ registration, a new program that builds on NSF’s GMP Registration Program.
- NSF International Awards First GMP for Sport(TM) Registration to Century Foods International
NSF International announced that Century Foods International is the first manufacturing facility to receive Good Manufacturing Practices (GMP) for Sport™ registration, a new program that builds on NSF’s GMP Registration Program.
- NSF International Awards First GMP for Sport(TM) Registration to Century Foods International
NSF International announced that Century Foods International is the first manufacturing facility to receive Good Manufacturing Practices (GMP) for Sport™ registration, a new program that builds on NSF’s GMP Registration Program.
- FDA Asks U.S. Marshals to Seize Dietary Supplements Products Being Promoted With Drug Claims
At the request of the U.S. Food and Drug Administration (FDA), on September 5, 2006, U.S. Marshals seized quantities of Ellagimax capsules, Coral Max capsules, Coral Max without Iron capsules, and Advanced Arthritis Support capsules distributed by Advantage Nutraceuticals L.L.C. of Fort Walton Beach, Florida, valued at approximately $55,000.00. The products are alleged to be in violation of the new drug and misbranding provisions of the Federal Food, Drug and Cosmetic Act.
- FDA Asks U.S. Marshals to Seize Dietary Supplements Products Being Promoted With Drug Claims
At the request of the U.S. Food and Drug Administration (FDA), on September 5, 2006, U.S. Marshals seized quantities of Ellagimax capsules, Coral Max capsules, Coral Max without Iron capsules, and Advanced Arthritis Support capsules distributed by Advantage Nutraceuticals L.L.C. of Fort Walton Beach, Florida, valued at approximately $55,000.00. The products are alleged to be in violation of the new drug and misbranding provisions of the Federal Food, Drug and Cosmetic Act.
- FDA Asks U.S. Marshals to Seize Dietary Supplements Products Being Promoted With Drug Claims
At the request of the U.S. Food and Drug Administration (FDA), on September 5, 2006, U.S. Marshals seized quantities of Ellagimax capsules, Coral Max capsules, Coral Max without Iron capsules, and Advanced Arthritis Support capsules distributed by Advantage Nutraceuticals L.L.C. of Fort Walton Beach, Florida, valued at approximately $55,000.00. The products are alleged to be in violation of the new drug and misbranding provisions of the Federal Food, Drug and Cosmetic Act.
- FDA Asks U.S. Marshals to Seize Dietary Supplements Products Being Promoted With Drug Claims
At the request of the U.S. Food and Drug Administration (FDA), on September 5, 2006, U.S. Marshals seized quantities of Ellagimax capsules, Coral Max capsules, Coral Max without Iron capsules, and Advanced Arthritis Support capsules distributed by Advantage Nutraceuticals L.L.C. of Fort Walton Beach, Florida, valued at approximately $55,000.00. The products are alleged to be in violation of the new drug and misbranding provisions of the Federal Food, Drug and Cosmetic Act.
- FDA Asks U.S. Marshals to Seize Dietary Supplements Products Being Promoted With Drug Claims
At the request of the U.S. Food and Drug Administration (FDA), on September 5, 2006, U.S. Marshals seized quantities of Ellagimax capsules, Coral Max capsules, Coral Max without Iron capsules, and Advanced Arthritis Support capsules distributed by Advantage Nutraceuticals L.L.C. of Fort Walton Beach, Florida, valued at approximately $55,000.00. The products are alleged to be in violation of the new drug and misbranding provisions of the Federal Food, Drug and Cosmetic Act.
- DEA: Hi-Tech Pharmaceuticals & 11 Individuals Indicted for "Generic" Pill Fraud Scheme
Hi-Tech Pharmaceuticals & 11 Individuals have been indicted by a federal grand jury on multiple felony charges relating to a scheme to sell adulterated and unapproved new drugs over the internet.
- DEA: Hi-Tech Pharmaceuticals & 11 Individuals Indicted for "Generic" Pill Fraud Scheme
Hi-Tech Pharmaceuticals & 11 Individuals have been indicted by a federal grand jury on multiple felony charges relating to a scheme to sell adulterated and unapproved new drugs over the internet.
- Navamedic’s product Glucomed®/Flexove(TM) approved in EU by CHMP
Navamedic has received notice that its glucosamine HCl product Glucomed®/Flexove(TM) has been recommended for approval by the Committee for Medicinal Products for Human Use (CHMP). The approval will be valid for all 25 EU/EEA countries in Navamedic’s application.
- Navamedic’s product Glucomed®/Flexove(TM) approved in EU by CHMP
Navamedic has received notice that its glucosamine HCl product Glucomed®/Flexove(TM) has been recommended for approval by the Committee for Medicinal Products for Human Use (CHMP). The approval will be valid for all 25 EU/EEA countries in Navamedic’s application.
- Navamedic’s product Glucomed®/Flexove(TM) approved in EU by CHMP
Navamedic has received notice that its glucosamine HCl product Glucomed®/Flexove(TM) has been recommended for approval by the Committee for Medicinal Products for Human Use (CHMP). The approval will be valid for all 25 EU/EEA countries in Navamedic’s application.
- Navamedic’s product Glucomed®/Flexove(TM) approved in EU by CHMP
Navamedic has received notice that its glucosamine HCl product Glucomed®/Flexove(TM) has been recommended for approval by the Committee for Medicinal Products for Human Use (CHMP). The approval will be valid for all 25 EU/EEA countries in Navamedic’s application.
- Navamedic’s product Glucomed®/Flexove(TM) approved in EU by CHMP
Navamedic has received notice that its glucosamine HCl product Glucomed®/Flexove(TM) has been recommended for approval by the Committee for Medicinal Products for Human Use (CHMP). The approval will be valid for all 25 EU/EEA countries in Navamedic’s application.
- Ontario Government Closer to Regulating Traditional Chinese Medicine
Ontario has moved closer to regulating traditional Chinese medicine (TCM) and acupuncture as the proposed legislation moved to second reading.
- Ontario Government Closer to Regulating Traditional Chinese Medicine
Ontario has moved closer to regulating traditional Chinese medicine (TCM) and acupuncture as the proposed legislation moved to second reading.
- Ontario Government Closer to Regulating Traditional Chinese Medicine
Ontario has moved closer to regulating traditional Chinese medicine (TCM) and acupuncture as the proposed legislation moved to second reading.
- FDA Authorizes Qualified Health Claim for Canola Oil
The U.S. Food and Drug Administration has announced that canola oil is now eligible to bear a qualified health claim on its ability to reduce the risk of coronary heart disease (CHD) due to its unsaturated fat content. The claim, which canola oil bottlers and makers of eligible products* may use on labels, states:
Limited and not conclusive scientific evidence suggests that eating about 1 1/2 tablespoons (19 grams) of canola oil daily may reduce the risk of coronary heart disease due to the unsaturated fat content in canola oil. To achieve this possible benefit, canola oil is to replace a similar amount of saturated fat and not increase the total number of calories you eat in a day. One serving of this product contains [x] grams of canola oil.
- FDA Authorizes Qualified Health Claim for Canola Oil
The U.S. Food and Drug Administration has announced that canola oil is now eligible to bear a qualified health claim on its ability to reduce the risk of coronary heart disease (CHD) due to its unsaturated fat content. The claim, which canola oil bottlers and makers of eligible products* may use on labels, states:
Limited and not conclusive scientific evidence suggests that eating about 1 1/2 tablespoons (19 grams) of canola oil daily may reduce the risk of coronary heart disease due to the unsaturated fat content in canola oil. To achieve this possible benefit, canola oil is to replace a similar amount of saturated fat and not increase the total number of calories you eat in a day. One serving of this product contains [x] grams of canola oil.
- FDA Authorizes Qualified Health Claim for Canola Oil
The U.S. Food and Drug Administration has announced that canola oil is now eligible to bear a qualified health claim on its ability to reduce the risk of coronary heart disease (CHD) due to its unsaturated fat content. The claim, which canola oil bottlers and makers of eligible products* may use on labels, states:
Limited and not conclusive scientific evidence suggests that eating about 1 1/2 tablespoons (19 grams) of canola oil daily may reduce the risk of coronary heart disease due to the unsaturated fat content in canola oil. To achieve this possible benefit, canola oil is to replace a similar amount of saturated fat and not increase the total number of calories you eat in a day. One serving of this product contains [x] grams of canola oil.
- FDA Authorizes Qualified Health Claim for Canola Oil
The U.S. Food and Drug Administration has announced that canola oil is now eligible to bear a qualified health claim on its ability to reduce the risk of coronary heart disease (CHD) due to its unsaturated fat content. The claim, which canola oil bottlers and makers of eligible products* may use on labels, states:
Limited and not conclusive scientific evidence suggests that eating about 1 1/2 tablespoons (19 grams) of canola oil daily may reduce the risk of coronary heart disease due to the unsaturated fat content in canola oil. To achieve this possible benefit, canola oil is to replace a similar amount of saturated fat and not increase the total number of calories you eat in a day. One serving of this product contains [x] grams of canola oil.
- FDA Authorizes Qualified Health Claim for Canola Oil
The U.S. Food and Drug Administration has announced that canola oil is now eligible to bear a qualified health claim on its ability to reduce the risk of coronary heart disease (CHD) due to its unsaturated fat content. The claim, which canola oil bottlers and makers of eligible products* may use on labels, states:
Limited and not conclusive scientific evidence suggests that eating about 1 1/2 tablespoons (19 grams) of canola oil daily may reduce the risk of coronary heart disease due to the unsaturated fat content in canola oil. To achieve this possible benefit, canola oil is to replace a similar amount of saturated fat and not increase the total number of calories you eat in a day. One serving of this product contains [x] grams of canola oil.
- FDA Authorizes Qualified Health Claim for Canola Oil
The U.S. Food and Drug Administration has announced that canola oil is now eligible to bear a qualified health claim on its ability to reduce the risk of coronary heart disease (CHD) due to its unsaturated fat content. The claim, which canola oil bottlers and makers of eligible products* may use on labels, states:
Limited and not conclusive scientific evidence suggests that eating about 1 1/2 tablespoons (19 grams) of canola oil daily may reduce the risk of coronary heart disease due to the unsaturated fat content in canola oil. To achieve this possible benefit, canola oil is to replace a similar amount of saturated fat and not increase the total number of calories you eat in a day. One serving of this product contains [x] grams of canola oil.
- Allimax Nutraceuticals US starts clinical trial for treating Lyme disease
Allimax Nutraceuticals US, in conjunction with the Health Healing and Hope Foundation, have started their Lyme disease double blind clinical study being conducted in Texas by Dr.’s Joan Vandergriff ND, Hamid Moayad DO, William Keller Ph.D., Hugo Rodier M.D.
- Allimax Nutraceuticals US starts clinical trial for treating Lyme disease
Allimax Nutraceuticals US, in conjunction with the Health Healing and Hope Foundation, have started their Lyme disease double blind clinical study being conducted in Texas by Dr.’s Joan Vandergriff ND, Hamid Moayad DO, William Keller Ph.D., Hugo Rodier M.D.
- Health Canada Issues 'Approach to the Refusal of Product license Applications'
Health Canada has issued a notice regarding its approach to the refusal of Product License Applications. The approach is posted at http://www.hc-sc.gc.ca/dhp-mps/prodnatur/bulletins/pl-ref-lp_e.html.
- Health Canada Issues 'Approach to the Refusal of Product license Applications'
Health Canada has issued a notice regarding its approach to the refusal of Product License Applications. The approach is posted at http://www.hc-sc.gc.ca/dhp-mps/prodnatur/bulletins/pl-ref-lp_e.html.
- Health Canada Issues 'Approach to the Refusal of Product license Applications'
Health Canada has issued a notice regarding its approach to the refusal of Product License Applications. The approach is posted at http://www.hc-sc.gc.ca/dhp-mps/prodnatur/bulletins/pl-ref-lp_e.html.
- Health Canada Approves Second Martek DHA For Food Uses
Company announces that now all of its DHA omega-3 products have been approved by Health Canada for use as food ingredients in most foods.
- Health Canada Approves Second Martek DHA For Food Uses
Company announces that now all of its DHA omega-3 products have been approved by Health Canada for use as food ingredients in most foods.
- Health Canada Approves Second Martek DHA For Food Uses
Company announces that now all of its DHA omega-3 products have been approved by Health Canada for use as food ingredients in most foods.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Another Reason to Choose Healthy Lifestyle Habits
- Another Reason to Choose Healthy Lifestyle Habits
|
Lipogen Ltd., Israel, announced today that the FDA has no questions regarding the GRAS notification for its Lipogen PS (phosphatidylserine) patented product line.
This “green-light” from FDA is a significant move for Lipogen as it aims our non-bacterial PS ingredient into the functional food and beverages marketplace,” says David Rutenberg, CEO at Lipogen
Lipogen is marketing its PS product, in both powder and liquid versions, worldwide. It can be applied to various key-category applications, such as milk, yogurt products, breakfast cereals, biscuits, meal replacements etc.
Based on the FDA GRAS approval, Rutenberg expresses confidence the company will expand its sales within the food and beverage industry. “The efficacy of PS has been recognized by the FDA which allows Qualified Health Claims (May 13, 2003). The GRAS affirmation of Lipogen PS as a functional food ingredient will greatly contribute to the fulfillment of consumer demand for mental functional supplements. Baby boomers are seeking for natural brain solutions that will prevent cognitive dysfunction.”
Phosphatidylserine is mostly found in brain cells and is involved in numerous functions of neuronal activity. Lipogen PS has been clinically tested in a double-blind, placebo-controlled studies. The research showed significant memory and mental improvements in comparison to the placebo groups.
Lipogen, a leading PS developer since 1992, focuses on natural mental health solutions for dietary supplements or for enhancing foods and beverages. All Lipogen products are vegetarian and kosher certified.
For further information, please contact:
David Rutenberg, CEO
Tel: +972 544 522 355
Fax : +972 3 548 0149
E-mail: info@lipogen.co.il
www.lipogen.co.il |